Abstract:Background: Severe pneumonia has consistently been associated with high mortality. We sought to identify risk factors for the mortality of severe pneumonia to assist in reducing mortality for medical treatment. Methods: Electronic databases including PubMed, Web of Science, EMBASE, Cochrane Library, and Scopus were systematically searched till June 1, 2023. All human research were incorporated into the analysis, regardless of language, publication date, or geographical location. To pool the estimate, a mixed-effect model was used. The Newcastle-Ottawa Scale (NOS) was employed for assessing the quality of included studies that were included in the analysis. Results: In total, 22 studies with a total of 3655 severe pneumonia patients and 1107 cases (30.29%) of death were included in the current meta-analysis. Significant associations were found between age [5.76 years, 95% confidence interval [CI] (3.43, 8.09), P < 0.00001], male gender [odds ratio (OR) = 1.47, 95% CI (1.07, 2.02), P = 0.02], and risk of death from severe pneumonia. The comorbidity of neoplasm [OR = 3.37, 95% CI (1.07, 10.57), P = 0.04], besides the presence of complications such as diastolic hypotension [OR = 2.60, 95% CI (1.45, 4.67), P = 0.001], ALI/ARDS [OR = 3.63, 95% CI (1.78, 7.39), P = 0.0004], septic shock [OR = 9.43, 95% CI (4.39, 20.28), P < 0.00001], MOF [OR = 4.34, 95% CI (2.36, 7.95), P < 0.00001], acute kidney injury [OR = 2.45, 95% CI (1.14, 5.26), P = 0.02], and metabolic acidosis [OR = 5.88, 95% CI (1.51, 22.88), P = 0.01] were associated with significantly higher risk of death among patients with severe pneumonia. Those who died, compared with those who survived, differed on multiple biomarkers on admission including serum creatinine [Scr: + 67.77 mmol/L, 95% CI (47.21, 88.34), P < 0.00001], blood urea nitrogen [BUN: + 6.26 mmol/L, 95% CI (1.49, 11.03), P = 0.01], C-reactive protein [CRP: + 33.09 mg/L, 95% CI (3.01, 63.18), P = 0.03], leukopenia [OR = 2.63, 95% CI (1.34, 5.18), P = 0.005], sodium < 136 mEq/L [OR = 2.63, 95% CI (1.34, 5.18), P = 0.005], albumin [- 5.17 g/L, 95% CI (- 7.09, - 3.25), P < 0.00001], PaO2/FiO2 [- 55.05 mmHg, 95% CI (- 60.11, - 50.00), P < 0.00001], arterial blood PH [- 0.09, 95% CI (- 0.15, - 0.04), P = 0.0005], gram-negative microorganism [OR = 2.56, 95% CI (1.17, 5.62), P = 0.02], and multilobar or bilateral involvement [OR = 3.65, 95% CI (2.70, 4.93), P < 0.00001]. Conclusions: Older age and male gender might face a greater risk of death in severe pneumonia individuals. The mortality of severe pneumonia may also be significantly impacted by complications such diastolic hypotension, ALI/ARDS, septic shock, MOF, acute kidney injury, and metabolic acidosis, as well as the comorbidity of neoplasm, and laboratory indicators involving Scr, BUN, CRP, leukopenia, sodium, albumin, PaO2/FiO2, arterial blood PH, gram-negative microorganism, and multilobar or bilateral involvement. Systematic review registration: PROSPERO Protocol Number: CRD 42023430684.

Analysis on Risk Factors of affecting Prognosis of Severe Pneumonia

Impact Clinically Related Factors on the Outcomes of Ventilator-Associated Pneumonia

Risk analysis of prognostic factors of 135 patients with severe acute pneumonia in the ICU

Risk factors for mortality of patients with pneumonia caused by Acinetobacter baumannii and Pseudomonas aeruginosa

Analysis of the risk factors and pathogenic bacteria of ventilator-associated pneumonia

Correlation between drug resistance of Pseudomonas aeruginosa causing pneumonia and mortality

Predictors of mortality in severe pneumonia patients: a systematic review and meta-analysis

Prognosis and Risk Factor of Patients with Pneumonia Caused by Acinetobacter Baumannii in ICU

Severe pneumonia in clinical practice

Investigation for prognosis of hospitalized patients with pulmonary tuberculosis and analysis for related factors

Analysis of 101 Cases of Pneumonia Deaths

A Clinical Analysis of Pathogens Resistance with Severe Pneumonia in Patient from Pediatric Intensive Care Unit

Study on the clinical characteristics, treatment, and outcome influencing factors of severe pneumonia complicated with ARDS

A retrospective analysis of risk factor, pathogen and prognosis of hospital-acquired pneumonia in adult patients in Shanghai

Risk Factors for Mortality of Inpatients with Pseudomonas aeruginosa Bacteremia in China: Impact of Resistance Profile in the Mortality

Prognostic factors related to community acquired pneumonia

Risk Factors of Prognosis of Acquired Septicemia from SICU: A Clinical Analysis

Diagnosis and Treatment of Severe Pneumonia Complicated with Rhabdomyolysis,acute Renal Failure and Review of Literatures

A prediction and interpretation machine learning framework of mortality risk among severe infection patients with pseudomonas aeruginosa

Clinical Analysis of 7 Pregnant Women with Severe Pneumonia

Risk factors analysis and prediction model construction for severe pneumonia in older adult patients